share_log

瑛泰医疗(01501.HK)：向中国证监会上海监管局提交上市辅导备案申请材料

Yingtai Healthcare (01501.HK): Submission of listing guidance and filing application materials to the Shanghai Regulatory Bureau of the China Securities Regulatory Commission

Gelonghui Finance ·  Apr 7 18:13

Gelonghui, April 7, 丨 Yingtai Medical (01501.HK) announced that on April 7, 2024, the company submitted listing guidance and filing application materials to the Shanghai Regulatory Bureau of the China Securities Regulatory Commission.

Due to business development needs, the company plans to prepare for listing on stock exchanges in China (“Recommended A-share listing”). The advising agency for A-share listing is China International Finance Co., Ltd. The proposed A-share listing is still in the early planning stage. As of the announcement date, the company has not submitted any formal listing application to any relevant regulatory authority in China.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment